{ }
001122334455554433221100
001122334455554433221100
Symbol ACRS
Name Aclaris Therapeutics, Inc.
Currency USD
Sector Health Care
IndustryGroup Pharmaceuticals, Biotechnology & Life Sciences
Industry Biotechnology
Market NASDAQ Global Select
Country United States
State PA
City Wayne
Zipcode 19087
Website http://www.aclaristx.com

cryopyrin-associated periodic syndrome pipeline analysis and key company insights

DelveInsight's report highlights the ongoing development of therapies for Cryopyrin-Associated Periodic Syndromes (CAPS) by key companies such as Novartis and Zydus Lifesciences. The pipeline includes several promising candidates in various clinical trial phases, with VTX2735 showing significant efficacy in a recent Phase 2 trial. CAPS, caused by NLRP3 gene mutations, leads to severe inflammatory episodes and requires effective treatment to prevent long-term damage.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.